104 related articles for article (PubMed ID: 6357205)
1. [Comparison of the activity of cefaclor with amoxicillin, erythromycin and doxycycline in an in vitro model].
Wiedemann B
Arzneimittelforschung; 1983; 33(9):1232-5. PubMed ID: 6357205
[TBL] [Abstract][Full Text] [Related]
2. [Bactericidal activity of amoxicillin and cefaclor in an "in vitro" kinetic model (author's transl)].
Pothier P; Kazmierczak A; Siebor E; Gaillard MC; Pechinot A
Ann Microbiol (Paris); 1981; 132(3):293-306. PubMed ID: 7027869
[TBL] [Abstract][Full Text] [Related]
3. [Susceptibility of Branhamella catarrhalis to antibiotics].
Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of oral beta-lactam antibiotics in plasma and urine versus isogenic Escherichia coli strains producing broad- and extended-spectrum beta-lactamases.
Bedenic B; Vranes J; Suto S; Zagar Z
Int J Antimicrob Agents; 2005 Jun; 25(6):479-87. PubMed ID: 15894465
[TBL] [Abstract][Full Text] [Related]
5. [The effect of subinhibitory concentrations of cefaclor, erythromycin and doxycycline on phagocytosis and intracellular killing of E. coli by human neutrophil granulocytes].
Stübner G
Arzneimittelforschung; 1986 Nov; 36(11):1702-4. PubMed ID: 3545226
[TBL] [Abstract][Full Text] [Related]
6. Summary of laboratory studies on the antibacterial activity of cefaclor.
Preston DA
Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
[TBL] [Abstract][Full Text] [Related]
7. [The effect of cefaclor, doxycycline and other oral antibiotics on phagocytosis of polymorphonuclear granulocytes and PHA-induced stimulation of blood lymphocytes in man].
Hahn H; Kuhring D; Trautmann M; Diamantstein T
Arzneimittelforschung; 1985; 35(2):543-6. PubMed ID: 3873244
[TBL] [Abstract][Full Text] [Related]
8. In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora.
Kaieda S; Yano H; Okitsu N; Hosaka Y; Okamoto R; Inoue M; Takahashi H
Int J Pediatr Otorhinolaryngol; 2005 Apr; 69(4):479-85. PubMed ID: 15763284
[TBL] [Abstract][Full Text] [Related]
9. Determination of the pharmacodynamic activity of clinically achievable tigecycline serum concentrations against clinical isolates of Escherichia coli with extended-spectrum beta-lactamases, AmpC beta-lactamases and reduced susceptibility to carbapenems using an in vitro model.
Zhanel GG; Baudry PJ; Tailor F; Cox L; Hoban DJ; Karlowsky JA
J Antimicrob Chemother; 2009 Oct; 64(4):824-8. PubMed ID: 19643776
[TBL] [Abstract][Full Text] [Related]
10. Ofloxacin: bactericidal effect in an in vitro pharmacokinetic model.
Xerri L; Broggio R; Guerra L
Chemioterapia; 1986 Apr; 5(2):83-7. PubMed ID: 3085961
[TBL] [Abstract][Full Text] [Related]
11. Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli.
Sorlózano A; Gutiérrez J; Romero JM; de Dios Luna J; Damas M; Piédrola G
J Basic Microbiol; 2007 Oct; 47(5):413-6. PubMed ID: 17910106
[TBL] [Abstract][Full Text] [Related]
12. Beta-lactam antibiotics functionalized with gem-bisphosphonates.
Hornyák M; Hartmann JF; Sztaricskai FJ; Koncz A; Hernádi F
Acta Pharm Hung; 1999 Sep; 69(4):213-7. PubMed ID: 10544522
[TBL] [Abstract][Full Text] [Related]
13. Global surveillance of bacterial susceptibility to cefaclor: 1988-1990.
Preston DA
Clin Ther; 1993; 15(1):88-96. PubMed ID: 8458058
[TBL] [Abstract][Full Text] [Related]
14. Laboratory and clinical studies of cefaclor in Japan.
Fujii R
Postgrad Med J; 1979; 55 Suppl 4():88-92. PubMed ID: 398486
[No Abstract] [Full Text] [Related]
15. Influence of amoxycillin and cefaclor on the colonization resistance of oropharynx.
van Saene HK; Willems FT; Zweens J
Scand J Infect Dis Suppl; 1983; 39():97-9. PubMed ID: 6359384
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli.
Puerto AS; Fernández JG; del Castillo Jde D; Pino MJ; Angulo GP
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):135-9. PubMed ID: 16406187
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity and pharmacokinetics of cefaclor in normal volunteers and patients with renal failure.
Levison ME; Santoro J; Agarwal BN
Postgrad Med J; 1979; 55 Suppl 4():12-6. PubMed ID: 548939
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.
Renkonen OV
Scand J Infect Dis Suppl; 1983; 39():106-8. PubMed ID: 6606222
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cefaclor.
Derry JE
Am J Hosp Pharm; 1981 Jan; 38(1):54-8. PubMed ID: 7011003
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial effect of oregano essential oil alone and in combination with antibiotics against extended-spectrum beta-lactamase-producing Escherichia coli.
Si H; Hu J; Liu Z; Zeng ZL
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):190-4. PubMed ID: 18435748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
